Takeda, Biological E. Team Up to Provide Dengue Vaccine Access to Endemic Countries
Current production of Qdenga will increase to 50 million doses a year.
The Perks of Medicare Advantage Versus Traditional Medicare
A cohort study explores the association of Medicare Advantage enrollment with post-acute care use, along with patient outcomes among retired state employees.
Healthcare Triangle Introduces New SaaS Solution
The company’s cloud technology services aim to assist healthcare and pharma with AI integration.
Identifying Trends Surrounding the Use of In-House Pharmacies for High-Cost Drugs
A cross-sectional study investigates how this supply chain link helps increase Medicare Part D spending on self-administered specialty drugs.
Fortrea Grows Its Non-Commercial Specialty Pharma Offering
The CRO’s FortreaRx doubles in size, including a boost in cold chain storage, while also continuing to improve its patient access services.
Investigating Trends in the Pharmaceutical Research & Development Space
The annual report published by IQVIA examines movement surrounding drug launches and new clinical trials, during the post-pandemic era.
Analyzing PCSK9 Inhibitor Use in Adults With Cardiovascular Disease
A cohort study investigates how a change in clinical guidelines, an expanded label, and reduction in drug prices can impact the use of PCSK9 inhibitors as a treatment for atherosclerotic cardiovascular disease.
LSPedia Introduces New Traceability Solution
OneScan 7.1 is expected to boost compliance, while also improving pharma supply chain efficiencies.
Calculating the Cost-Effectiveness of Empagliflozin in Patients Experiencing Heart Failure
A trial set out to determine whether empagliflozin can help prevent hospitalizations and extend life for patients with heart failure, while not hurting the US payers’ pockets.
Merck’s Primary Advanced, Recurrent Endometrial Carcinoma Treatment Given Priority Review by FDA
Phase III results from Keytruda (pembrolizumab)’s NRG-GY018 trial help influence the agency’s decision.
Opthea Hires New Chief Medical Advisor
Arshad M. Khanani, MD, MA, FASRS, will help lead development efforts for sozinibercept, a potential wet AMD treatment.
Almirall, Novo Nordisk Reach Licensing Agreement Surrounding IL-21 Blocking Monoclonal Antibodies
As part of the agreement, Novo will be paid both development and commercial milestone payments for NN-8828, is currently in Phase II of non-dermatological indications.
FDA Accepts Biologics License Application for Datopotamab Deruxtecan
The agency will make its final decision surrounding the locally advanced or metastatic nonsquamous NSCLC drug —based on results from the TROPION-Lung01 Phase III trial—by Q4 2024.
ValGenesis, RxCloud Collaborate on Tackling Compliance and Quality Assurance Challenges
The partnership revolves around meeting various agency standards and industry requirements pertaining to the drug development and manufacturing lifecycle.
Schreiner MediPharm Unveils New Closure Seals for Pharma Packaging
The new seals include sustainable film material containing recyclate content of up to 90%.
DHL Supply Chain Invests $200M Toward Expanding Its Life Sciences and Healthcare Services
The financial commitment features construction of new warehouses in Pennsylvania and North Carolina.
Using Machine Learning to Predict Cancer Treatment Effectiveness
Scientists develop algorithms that can not only identify tumors that will respond well to chemotherapy, but which are also likely to resist treatment.
How Are High Drug Prices Justified?
Analysis explores where drug prices are derived from, and whether a holistic societal approach can help determine these products’ true value.
Analyzing State-Based Legislation Surrounding Medical Freedom, Stem Cell Procedures
Examination evaluates investigational stem cell interventions, including how the states have implemented their own policies when it comes to their uses.
Can Lower Out-of-Pocket Costs Help Improve Diabetes Patients’ Short-Term Health?
Cohort study explores value-based insurance designs, while also determining how one’s place of residency can potentially play a role.
Study Highlights the Value of Patient Support Programs
Researchers explore the proportion of approved drugs in the Canadian marketplace that utilize manufacturer-sponsored patient support programs, along with the types of medications that are more likely to do so.
Erectile Dysfunction Meds Could Be Associated With Lowering Alzheimer's Disease Risk
Investigators examine the validity of phosphodiesterase type 5 inhibitors for erectile dysfunction, such as Viagra, being repurposed for the treatment of Alzheimer's disease.
Determining the Efficacy of Bivalent COVID-19 Vaccines in Children and Adolescents
A study investigates the effectiveness of bivalent mRNA COVID-19 vaccines against the Omicron variant among participants 5-17 years of age.
BridgeBio Pharma Receives FDA Acceptance of New Drug Application Filing for Acoramidis
Trial for the treatment of ATTR-CM demonstrated an 81% absolute survival rate, along with an observed mean annual CVH frequency of 0.29.
Exploring the Frequency That Beneficiaries Encounter Subsidy Losses Attributed to Medicare Part D’s Low-Income Subsidy Program
Cohort study dives into whether low income subsidy losses are associated with disability status, age, and race and ethnicity.
The Correlation Between a New York State Law Repeal and Vaccine Coverage in Schools
A cohort study investigates the impact of Senate Bill 2994A and answers the question: does the repeal of school-entry nonmedical vaccination exemptions result in a rise in school vaccinations?
New Year, New Aspirations
Pharma Commerce's new style is built off of the back of our new and improved editorial calendar.
Access Insights and Information Abound
Pharma Commerce travels to Orlando for a pulse-check on this fast-evolving landscape in patient care.
A Comparison of Prescription Drug Availability
An analysis conducted by RAND Corporation determines that majority of new Rx medications are first sold in the United States before making their debut in other countries.
The Path for Prescription Drug Sales
A dive into this market reveals that the latest numbers yield promising results—a global value of a worldwide $1.6 trillion—but it will continue to be attributed to past, present, and future healthcare spending.